A cell surface 230 kDa protein from murine melanoma involved with tumor malignancy

Cancer Letters

Volumn 262, Issue 2, 2008, Pages 276-285

  Mendes, Priscila Fraga Penteado ^a   Xander, Patrícia ^a   Brito, Ronni Rômulo Novaes e ^a   Mortara, Renato Arruda ^a   Jasiulionis, Miriam Galvonas ^a   Lopes, José Daniel ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Immunotherapy; Malignancy; Monoclonal antibody; Murine melanoma; Tumor marker

Indexed keywords

MELANOMA ANTIGEN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY G12F2; TUMOR MARKER; UNCLASSIFIED DRUG;

ADOLESCENT; ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CANCER IMMUNOTHERAPY; CARCINOGENESIS; CELL PROLIFERATION; HUMAN; HUMAN CELL; IMMUNOTHERAPY; LUNG METASTASIS; MALE; MELANOMA; MELANOMA CELL; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH;

MURINAE;

EID: 40649094490     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2007.12.017     Document Type: Article

References (44)

1. E.R. Sauter M. Herlyn Molecular biology of human melanoma development and progression Mol. Carcinog. 23 1998 132 143
2. F.O. Nestle G. Burg R. Dummer New perspectives on immunobiology and immunotherapy of melanoma Immunol. Today 20 1999 5 7
3. r 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype Cancer Res. 60 2000 5848 5856
4. C.J. Kim S. Dessureault D. Gabrilovich D.S. Reintgen C.L. Slingluff Immunotherapy for melanoma Cancer Control 9 2002 22 30
5. I. Komenaka H. Hoerig H. Kaufman Immunotherapy for melanoma Clin. Dermathol. 22 2004 251 265
6. Y. Chudnovsky P. Khavari A.E. Adams Melanoma genetics and the development of rational therapeutics J. Clin. Invest. 115 2005 813 824
7. A. Tarhini S.S. Agarwala Cutaneous melanoma: available therapy for metastatic disease Dermathol. Ther. 19 2006 19 25
8. A. Jemal R. Siegel E. Ward Cancer statistics CA Cancer J. Clin. 56 2006 106 130
9. B. Kasper V. D’Hondt P. Vareecken A. Awada Novel treatment strategies for malignant melanoma: a new beginning? Crit. Rev. Oncol. Hematol. 62 2007 16 22
10. P.C. Brooks J.-M. Lin D.L. French J.P. Quigley Subtractive immunization yields monoclonal antibodies that specifically inhibit metastasis J. Cell. Biol. 122 1993 1351 1359
11. K. Satyamoorthy M. Herlyn Cellular and molecular biology of human melanoma Cancer Biol. Ther. 1 2002 14
12. S. Wagner C. Hafner D. Allwardt J. Jasinska S. Ferrone C.C. Zielinski O. Scheiner U. Wiedermann H. Pehamberger H. Breiteneder Vaccination with a human molecular weight melanoma-associated antigen mimotope induces a humoral response inhibiting melanoma cell growth in vitro J. Immunol. 174 2005 976 982
13. J.C. Becker E.B. Bröcker Lymphocyte–melanoma interaction: role of surface molecules Rec. Resul. Cancer Res. 139 1995 205 214
14. H. Koprowski Z. Steplewski D. Herlyn M. Herlyn Study of antibodies against human melanoma produced by somatic cell hybrids Proc. Natl. Acad. Sci. USA 75 1978 3405 3409
15. K. Sikora Monoclonal antibodies in oncology J. Clin. Pathol. 35 1982 369 375
16. G. Kohler C. Milstein Continuous cultures of fused cells secreting antibody of predefined specificity Nature 256 1975 495 497
17. I. Melero S. Hervas-Stubbs M. Glennie D.M. Pardoll L. Chen Immunostimulatory monoclonal antibodies for cancer therapy Nat. Rev. Cancer 7 2007 95 106
18. C.S. Pukel K.O. Lloyd L.R. Travassos W.G. Dippold H.F. Oettgen L.J. Old GD3, a proeminent ganglioside of human melanoma-detection and characterization by mouse monoclonal antibody J. Exp. Med. 155 1982 1133 1147
19. I. Hellström V. Brankovan K. Hellström Strong antitumor activities of IgG3 antibodies to a human melanoma-associated gangliosides Proc. Natl. Acad. Sci. USA 82 1985 1499 1502
20. Y. Nishinaka M.H. Ravindranath R.F. Irie Development of a human monoclonal antibody to ganglioside GM2 with potential for cancer treatment Cancer Res. 56 1999 5666 5671
21. M.W. Retter J.C. Johnson D.W. Peckham J.E. Bannnink C.S. Bangur K. Dresser F. Cai T.M. Foy N.A. Fanger G.R. Fanger B. Woda Characterization of a proapoptotic antiganglioside GM2 monoclonal antibody and evaluation of its therapeutic effect on melanoma and small cell lung carcinoma xenografts Cancer Res. 65 2005 6425 6434
22. L. Mills C. Tellez S. Huang C. Baker M. McCarty L. Green J.M. Gudas X. Feng M. Bar-Eli Fully human antibody to MCAM/MUC18 inhibit tumor growth and metastasis of human melanoma Cancer Res. 62 2002 5106 5114
23. E.C. McGary A. Heimberger L. Mills K. Weber G.W. Thomas M. Shtivelband L. Chelouche M. Bar-Eli A fully human antimelanoma cellular adhesion molecule/MUC18 antibody inhibits spontaneous pulmonary metastasis of osteorsarcoma cells in vivo Clin. Cancer Res. 15 2003 6560 6566
24. I.-M. Shih D.E. Elder D. Speicher J.P. Johnson M. Herlyn Isolation and functional characterization of the A32 melanoma-associated antigen Cancer Res. 54 1994 2514 2520
25. S. Junnikkala J. Hakulinen S. Meri Target neutralization of the complement membrane attack complex inhibitor CD59 on the surface of human melanoma cells Eur. J. Immunol. 24 1994 611 615
26. L. You B. He Z. Xu K. Uematsu J. Mazieres N. Fujii I. Mikami N. Reguart J.K. McIntosh M. Kashani-Sabet F. McCormick D.M. Jablons An anti-wnt-2 monoclonal antibody induces apoptosis in malignant melanoma cells and inhibits tumor growth Cancer Res. 64 2004 5385 5389
27. U. Trefzer Y. Chen G. Herberth M.A. Hofmann F. Kiecker Y. Guo W. Sterry The monoclonal antibody SM5-1 recognizes a fibronectin variant which is widely expressed in melanoma BMC Cancer 6 2006 1 12
28. J.D. Wolchok Y.M. Saenger Curr. Top. Melanoma 19 2007 116 120
29. C.W. Johnson R.F. Barth D. Adams B. Holman J.E. Price I. Sautins Phenotypic diversity of murine B16 melanoma detected by anti-B16 monoclonal antibodies Cancer Res. 47 1987 1111 1117
30. G. Poste J. Doll A.E. Brown J. Tzeng I. Zeidman Comparison of the metastatic properties of B16 melanoma clones isolated from cultured cell lines, subcutaneous tumors, and individual lung metastases Cancer Res. 42 1982 2770 2778
31. I.J. Fidler Selection of successive tumor lines for metastasis Nat. New Biol. 242 1973 148 149
32. I.J. Fidler Tumor heterogeneity and the biology of cancer invasion and metastasis Cancer Res. 28 1978 2651 2660
33. F.I. Staquicini C.R. Moreira F.D. Nascimento I.L.S. Tersariol H.B. Nader C.P. Dietrich J.D. Lopes Enzyme and integrin: expression by high and low metastatic melanoma cell lines Melanoma Res. 13 2003 11 18
34. S.M. Oba-Shinjo M. Correa T.I. Ricca F. Molognoni M.A. Pinhal I. Neves S.K. Marie L.O. Sampaio H.B. Nader R. Chammas M.G. Jasiulionis Melanocytes transformation associated with substrate adhesion impediment Neoplasia 8 2006 231 241
35. M. Correa J. Machado Jr. C.R.W. Carneiro J.B. Pesquero M. Bader L.R. Travassos R. Chammas M.G. Jasiulionis Transient inflammatory response induced by apoptotic cells is an important mediator of melanoma cell engraftment and growth Int. J. Cancer 114 2005 356 363
36. J.D. Lopes, M.J.M. Alves, Production of monoclonal antibodies by somatic cell hybridization, in: C.M. Morel (Ed.), Genes and Antigens of Parasites: A laboratory Manual (UNDO/World bank/WHO), Fundação Oswaldo Cruz, R.J., 1983, pp. 419–431.
37. T. Mosmann Rapid colorimetric assay for growth and survival: application to proliferation and cytotoxicity assays J. Immunol. Methods 65 1983 55 63
38. C. Garbe P. Buttner J. Bertz G. Burg B. d’Hoedt H. Drepper I. Guggenmoos-Holzmann W. Lechner A. Lippold C.E. Orfanos Primary cutaneous melanoma: identification of prognostic groups and estimation of individual prognosis for 5093 patients Cancer 75 1995 2484 2491
39. C.M. Balch S.J. Soong J.E. Gershenwald J.F. Thompson D.S. Reintgen N. Cascinelli M. Urist K.M. McMasters M.I. Ross J.M. Kirkwood M.B. Atkins J.A. Thompson D.G. Coit D. Byrd R. Desmond Y. Zhang P.Y. Liu G.H. Lyman A. Morabito Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system J. Clin. Oncol. 19 2001 3622 3634
40. A.A. Tarhini S.S. Agarwala Novel agents in development for treatment of melanoma Expert. Opin. Invest. Drugs 14 2005 885 892
41. P. Carter Improving the efficacy of antibody-based cancer therapies Nature Rev. Cancer 1 2001 118 129
42. K. Imai A. Takaoka Comparing antibody and small-molecule therapies for cancer Nat. Rev. Cancer 6 2006 714 727
43. J.M. Kirkwood S. Moschos W. Wang Strategies for the development of more effective adjuvant therapy of melanoma: current and future explorations of antibodies, cytokines, vaccines, and combinations Clin. Cancer Res. 12 7 2006 2331 2336
44. A.C.E. Campos F. Molognoni F.H.M. Melo L.C. Galdieri C.R.W. Carneiro V. D’Almeida M. Correa M.G. Jasiulionis Oxidative stress modulates DNA methylation during melanocyte anchorage blockade associated with malignant transformation Neoplasia 9 2007 1111 1121